Drug Discovery is an international journal covers research in Drug Design, drug discovery, drug development and its technologies. The journal provides an academic platform for drug-discovery professionals and researchers those working in the fields of Biological Chemistry, Bio-markers,
Biomedical engineering, Biotechnology, Chemical Biology, Chemistry, Clinical trials, Drug commercial and regulatory issues, Drug management, Drug patents, Drug-Informatics, FDA approvals, Genetics, Genomics, Medicine, Nanotechnology, Pharmaceutical R & D, Pharmacognosy, Pharmacology, Phytochemistry, Proteomics, Receptors, Therapeutic targets, Microbiology, Cell Biology, Structural & Molecular Biology. It serves as a forum for exchange of views and ideas among working scientists and theorists who seeks to promote and disseminate the knowledge by publishing original research findings, review articles, analysis, perspectives, opinion and communications in the field of Drug Discovery.
Manuscripts have to be double-spaced with one-inch margins. Headings must be used to designate the major divisions of the paper. To facilitate the review process, manuscripts should contain page and line numbering.
Manuscripts must be written in English. Authors whose native language is not English are strongly advised to have their manuscript checked by a language editing service, or by an English mother-tongue colleague prior to submission.
As part of the submission process, authors are required to check off the Submission Preparation Checklist, and submissions may be returned to authors that do not adhere to these guidelines.